Taken together, our findings highlight the sex‐related differences promoted by LDH‐A in immune reshaping in melanoma, and suggest that therapeutic targeting of LDH‐A could be leveraged as an effective strategy to abolish the sex‐gap in melanoma progression. Here, LDHA is linked to melanoma.